Source comparison
TB-500 Hair Growth Research — Comparison of Evidence Quality
Murine dermal wound healing C57BL/6 mice (n=24) Re-epithelialization rate at day 7 85% closure (TB-500) vs 58% (control) Demonstrates wound repair efficacy. Not follicular cycling Rat whisker follicle regrowth Sprague-Dawley rats (n=16) Telogen duration post-p
This comparison does not assign a generated winner or score.
- Murine dermal wound healing
- C57BL/6 mice (n=24)
- Re-epithelialization rate at day 7
- 85% closure (TB-500) vs 58% (control)
- Demonstrates wound repair efficacy. Not follicular cycling
- Rat whisker follicle regrowth
- Sprague-Dawley rats (n=16)
- Telogen duration post-plucking
- 15% reduction in telogen phase
- Whisker follicles regenerate robustly under baseline conditions. Poor model for human androgenic alopecia
- Human androgenic alopecia trials
- None published
- N/A
- Zero controlled trials exist. All claims are extrapolation
- Human alopecia areata trials
- No immune-modulation data in autoimmune hair loss
- Equine tendon injury (veterinary)
- Standardbred horses (n=42)
- Ultrasonographic lesion size reduction
- Significant improvement vs placebo (p<0.05)
- Validates TB-500 for soft tissue repair. Unrelated to follicular biology